Seelos Therapeutics, Inc.: Clinical Trials

5 trials sponsored by Seelos Therapeutics, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 no longer available, 1 terminated, 1 withdrawn. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Terminated 1, Withdrawn 1
Phase 32Completed 1, Terminated 1

Follow Seelos Therapeutics, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease
SLS-005 - Once Weekly, SLS-005 - Twice Weekly - Alzheimer's Disease
Phase 2WithdrawnSeelos Therapeutics, Inc.2023-03-032023-04-11
STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
SLS-005, Placebo - Spinocerebellar Ataxia Type 3
Phase 2 / Phase 3TerminatedSeelos Therapeutics, Inc.232022-06-032024-04-24
HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose
SLS-005, Matching Placebo - Amyotrophic Lateral Sclerosis
Phase 2 / Phase 3CompletedMerit E. Cudkowicz, MD1612022-02-212025-05-14
A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
SLS-002, Placebo, Standard of care - Depressive Disorder, Major, Suicidal
Phase 2CompletedSeelos Therapeutics, Inc.1642020-12-172023-09-28
Intermediate-Sized Expanded Access Study
Trehalose - Amyotrophic Lateral Sclerosis
No longer availableSeelos Therapeutics, Inc.2025-09-02

Conditions studied

Amyotrophic Lateral Sclerosis (2)  ·  Alzheimer Disease (1)  ·  Behavioral Symptoms (1)  ·  Dementia (1)  ·  Depression (1)  ·  Depressive Disorder (1)  ·  Depressive Disorder, Major (1)  ·  Machado-Joseph Disease (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)  ·  Self-Injurious Behavior (1)  ·  Suicidal Ideation (1)  ·  Suicide (1)

Interventions

Ketamine (1)  ·  Standard of Care (1)  ·  Trehalose (1)

Countries

United States (4)  ·  Australia (2)  ·  Brazil (1)  ·  Germany (1)  ·  Portugal (1)  ·  South Korea (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

James D Berry, MD,MPH (1)  ·  Merit Cudkowicz, MD (1)  ·  Sabrina Paganoni, MD,PhD (1)  ·  Suma Babu, MD,MPH,MBBS (1)

Results publications

PMID 40409314, PMID 40857020

NIH funding

UF1NS131791 (1)